Investing Profile

Rowan Chapman

VC
Photo of Rowan Chapman, Managing Director at Johnson & Johnson Innovation

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Cambridge Network
79 CONNECTIONS
University of Cambridge Network
79 CONNECTIONS
Johnson & Johnson Network
17 CONNECTIONS
GE Network
15 CONNECTIONS
GE Network
15 CONNECTIONS
cb
5
CompanyStageDateRound SizeTotal Raised
Cornerstone AI
SeedOct 2024$5M
SeedJul 2022$5M
$15M
Co-investors: Vishal Lugani (aCrew Capital), Anya Schiess (J.P. Morgan Chase & Co.), Travis May
Personalis
Series CJan 2015$33M
Series BOct 2013$22M
Series AAug 2011$20M
$75M
Co-investors: Andrew Chung (1955 Capital), Chris Schaepe
Head of Johnson & Johnson Innovation California Johnson & Johnson2017 - Present
Head of Healthcare Investing GE2015 - Present
Managing Director, New Business Creation, GE Ventures GE2014 - 2015
Head of Precision Diagnostics, Life Sciences GE Healthcare2012 - 2014
Sponsor Rock Health2011 - 2014
Partner Mohr Davidow Ventures2001 - 2012
Business Consultant Allen Institute for Brain Science2004 - 2004
Director of Business Development Rosetta Inpharmatics1999 - 2001
Product Marketing Manager Incyte Genomics1997 - 1999
University of California, San Francisco Postdoctoral Research Walter Lab, Biochemistry
University of Cambridge Doctor of Philosophy (Ph.D.) Biochemistry and Molecular Biology
University of Cambridge Bachelor of Arts (B.A.) Biochemistry, First class honors